Novo Nordisk's stock fell after semaglutide's Alzheimer's news. Click here for how strong fundamentals and growth catalysts ...

CRN shared the latest development on a New York law restricting the sale of certain dietary supplements to individuals under ...

Novo and Lilly just slashed prices on GLP-1 weight-loss drugs that recently cost over $1,000 a month. What happened?

The weight-loss drug eloralintide shows up to 20% body weight reduction in trial, offering hope for obesity treatment beyond ...

Novo Nordisk said an older version of its weight-loss drug semaglutide failed to meet its main goal in late-stage trials ...

Orforglipron works by helping the body release insulin and lower another hormone called glucagon. This helps reduce blood ...

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

Behind the social media hype lies a troubling truth – Molecule contains a compound banned in most Western countries for its ...

New GLP-1 weight-loss drugs may preserve muscle, protect skin, and reduce the risk of "Ozempic face." Experts explain what ...

Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by ...

It's now just five weeks until Christmas - the season which, for most of us, means a hefty dose of over-indulgence.

Serena Williams has endorsed GLP-1 medications, raising questions regarding their stigma and performance-enhancing potential for athletes.